Stock Market News & Analysis
stocks
Stock showdown: Could these ASX fuel players tempt income investors?
Rising EV uptake and the future of refining in Australia are sources of uncertainty, but Ampol and Viva may still offer value.
stocks
3 overvalued ASX stocks with cheaper alternatives
Finding truly comparable companies is always hard, but these global and domestic peers could offer better value.
stocks
Deliveries at Tesla fall for second straight quarter
Tesla’s current product lineup may have reached market saturation. But investors have high hopes its robotaxi business.
stocks
The 10 best US companies to invest in now
These high-quality companies offer the best stocks to buy today.
stocks
Market too pessimistic on ASX share’s long-term prospects
Shares plunge 16% on leadership change.
stocks
Ask the analyst: Can ASX growth story turn a profit before it’s too late?
This healthcare company still has plenty of growth potential, but it’s been a rocky road for investors recently.
stocks
12 picks for an income portfolio - Q2 2025 update
One year in and passive income growth has exceeded my target.
stocks
Stock showdown: Does Sigma Healthcare deserve a similar market value to Woolies?
Sigma’s merger with Chemist Warehouse has brought one of Australia’s best retail businesses to the public.
stocks
Bolt-on acquisition adds capabilities for undervalued ASX share
Shares are trading at a 61% discount to our fair value.
stocks
How to understand potential investments at a deeper level
Asking these simple questions can reveal valuable things about a company’s quality and economics.
stocks
ASX healthcare leader undervalued after share slump
The sell-off in this moated healthcare company ignores strong potential for revenue growth and margin improvement.
stocks
Our view on Xero’s big bet
The shares sold off after the announcement of the Melio Payments acquisitions.
stocks
10 cheap wide-moat US stocks for 2025
Undervalued high-quality names from the Morningstar Wide Moat Focus Index are attractive stocks to buy for long-term investors.
stocks
Ask the analyst: Why does the Santos story need to end like this?
Santos’ disappointing returns over the past twenty years are mostly a result of bad timing. The timing of its potential departure from the ASX could also be unfortunate.
of 237
Viewing 1 to 16 of 3784